Clinicians' guide to lipids and coronary heart disease

Author(s)

• Betteridge, John
• Morrell, J. M. (Janet M.)

Bibliographic Information

Clinicians' guide to lipids and coronary heart disease

D.J. Betteridge and J.M. Morrell

（Clinicians' guides）

Arnold , Oxford University Press [distributor], 2003

2nd ed

Other Title

Lipids and coronary heart disease

Note

Includes bibliographical references and index

HTTP:URL=http://www.loc.gov/catdir/enhancements/fy0615/2003276398-d.html Information=Publisher description

HTTP:URL=http://www.loc.gov/catdir/enhancements/fy0615/2003276398-t.html Information=Table of contents only

Description and Table of Contents

Description

This fully updated revision of the well-received first edition continues to provide a clear, comprehensive and up-to-date account of the role of lipid management in the prevention of coronary heart disease. Appropriate for the clinician managing lipid problems in either the primary or secondary care setting, the well-respected author team consider all aspects of screening, diagnosis and risk assessment, and management. The science underlying lipid metabolism is put into context for the practising physician, including recent developments in inflammation, plaque biology and the transition to serious events. Risk factor modification, including lifestyle change and cholesterol lowerinig by diet and medication are discussed fully. Landmark clinical trials, and the messages that can be drawn from them, are highlighted throughout. The practical focus is maintained through the consideration of specific patient groups demonstrating particular clinical importance, management difficulties or highlighting areas of current controversy. With a balanced, readable style and clear explanatory illustrations, this second edition provides invaluable advice for primary care and specialist clinicians, whether in training or in practice, in the management of lipid disorders and the prevention of cardiovascular events.

Table of Contents

Part 1 Background Lipid and lipoprotein metabolism - the basics Epidemiology Part 2 Screening and Assessment Diagnosis Screening Risk factors and their assessment Part 3 Intervention Non-lipid risk factor modification Diet Lipid lowering drugs Lipid lowering trials Part 4 Practical considerations and special areas Meeting the challenge Special areas Economic aspects Case studies.

by "Nielsen BookData"

Details

• NCID: BA7805409X
• ISBN:
  • 0340764082
• LCCN: 2003276398
• Country Code: uk
• Title Language Code: eng
• Text Language Code: eng
• Place of Publication: London,New York
• Pages/Volumes: xvi, 368 p.
• Size: 25 cm
• Classification:
  • LCC : QP751
  • NLM : 2003 E-416
  • NLM : WD 200.5.H8
  • DC22 : 616.1/23071
• Subject Headings:
  • LCSH : Lipids -- Metabolism
  • LCSH : Coronary heart disease -- Etiology
  • LCSH : Cholesterol
  • LCSH : Anticholesteremic agents
  • MESH : Hyperlipidemia -- complications
  • MESH : Hyperlipidemia -- diet therapy
  • MESH : Hyperlipidemia -- drug therapy
  • MESH : Antilipemic Agents -- therapeutic use
  • MESH : Coronary Disease -- prevention & control
  • MESH : Lipids -- metabolism
• Parent Bibliography ID:
  • BA62883142